16:00 May 29

Cipla Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1401.00
-17.20 (-1.21%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Cipla Ltd. Financials

Cipla Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1401.00
-17.20 (-1.21%)
16:00 May 29
Quality
image/svg+xml

39/100
Medium Financial Strength

Valuation
image/svg+xml

34/100
Mid Valuation

Technical

45/100
Technically Neutral

Strength

5

Weakness

9

Opportunity

0

Threats

1

11.26 %

ROE %

9.12 %

ROA %

48.02

EPS

426.24

BVPS

13.77 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
21763.34 22753.12 25774.09 27547.62 28162.59
Operating Expenses +
17210.56 17726.15 19483.04 20419.72 22279.69
Raw Material
9220.29 8348.28 8756.54 9261.09 10292.99
Increase Decrease in Cost
-724.69 -96 63.03 -332.1 -743.88
Other Manufacturing Expense
0 0 640.62 667.72 0
Employee Cost
3529.91 3830.08 4310.04 4832.83 5366.33
Miscellaneous Expenses
12559.37 11301.11 12784.87 13693.16 16266.99
Operating Profit
4552.78 5026.97 6291.05 7127.9 5882.9
Other Income
280.91 475.45 746.57 861.87 882.01
Depreciation
1051.95 1172.11 1051.02 1106.95 1210.98
Interest
106.35 109.54 89.88 62.01 54.39
Profit before tax and exceptio..
3675.39 4220.77 5896.72 6820.81 5499.54
Exceptional Items
-182.12 -182.42 -194.82 0 -275.91
PBT
3493.27 4038.35 5701.9 6820.81 5223.63
Provision for Taxation
933.8 1202.86 1546.59 1529.76 1353.84
Net Profit
2559.47 2835.49 4155.31 5291.05 3869.79
NET Profit after MI
2516.75 2801.91 4121.55 5272.52 3879.23
EPS
31.17 34.69 51.01 65.29 48.03
Operating Profit Margin (%)
20.92 22.09 24.41 25.87 20.89
Net Profit Margin (%)
11.56 12.31 15.99 19.14 13.77

Cipla Ltd. Shareholding

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 29.20 29.20 29.20 29.20 29.20 29.20
FII 22.60 23.90 24.50 25.20 26.30 26.60
Public 31.90 30.70 30.30 29.30 28.10 27.80
Others 16.30 16.20 16.00 16.30 16.40 16.40
Shareholder Shares Holding %
Download Our App On: